A Systematic Review and Meta-Analysis of Rituximab in Antibody-mediated Renal Allograft Rejection
نویسندگان
چکیده
BACKGROUND The standard treatment of antibody-mediated rejection (AMR) consists of antilymphocyte antibody, intravenous immunoglobulin, and plasmapheresis. This treatment is associated with a high rate of resistance and refractory AMR. Recent interest has focused on use of rituximab (RTX), a chimeric anti-CD20 monoclonal antibody. OBJECTIVE We conducted a systematic review and meta-analysis of studies of RTX in AMR of the renal allograft. METHODS Combining two comprehensive search themes (AMR and RTX), we searched electronic databases from 1969 through 2010, supplemented by a manual review of abstracts from nephrology and transplant meetings, and reference lists of review articles. All studies evaluating explicit response of patients with AMR to RTX were included. The outcome was pooled odds ratio (OR) of response to RTX. RESULTS A total of 114 studies were identified, 94 of which were excluded on initial screening. Analysis of the 10 studies (249 patients) showed an OR of 3.16 (95% CI: 1.75-5.70) for response to RTX. Reported adverse effects included BK virus nephropathy, cytomegalovirus (CMV) viremia, pneumonia, herpes zoster, and septic shock. CONCLUSION This study suggests that RTX is a reasonable therapeutic option in the treatment of AMR. Further randomized studies are necessary to establish its efficacy and safety.
منابع مشابه
Effects of CD20+ B-cell infiltration into allografts on kidney transplantation outcomes: a systematic review and meta-analysis
The effects of CD20+ B-cell infiltration during acute rejection on graft outcomes are controversial. The objective of this systematic review and meta-analysis was to clarify this issue. We performed a systematic literature search for studies published up to January 14, 2016. A total of 5 studies, with 200 patients, were included. The presence of CD20+ B cells in renal biopsies during allograft ...
متن کاملClinical Management of Kidney Allograft Dysfunction
Allograft dysfunction is a common problem after kidney transplant. Allograft rejection is an important entity, and timely diagnosis and appropriate treatment are essential for caring transplant recipients. Hyperacute rejection is mediated by the preformed donor specific antibody, while accelerated acute rejection represents an anamnestic response by memory B and T cells. They occur early after ...
متن کاملPlasmapheresis and Intravenous Immunoglobulin in the Treatment and Prevention of Antibody Mediated Rejection
Background: Acute antibody-mediated rejection (AMR) is a rare complication which often results in the loss of kidney graft. The objective of this retrospective monocentric study was to evaluate three different approaches to AMR. Methods: We retrospectively evaluated data files from 1226 patients who had undergone renal transplantation in 1/2002 – 12/2008. In 2002 2003, patients with AMR were tr...
متن کاملAbsence of Intragraft B Cells in Rejection Biopsies After Rituximab Induction Therapy: Consequences for Clinical Outcome
BACKGROUND The pathophysiological role of intragraft B cells during renal allograft rejection is unclear. METHODS We studied B-cell infiltration during acute rejection in 53 patients who participated in a clinical trial in which adult renal transplant patients were randomized between a single intraoperative dose of rituximab (375 mg/m2) or placebo as induction therapy. Two independent patholo...
متن کاملDual pathology as a cause of proteinuria in the post-transplant period; report of a case
Proteinuria is common after renal transplantation and affects between 35%-45% of patients during the same year as their transplant. We report a case of dual pathology in the renal allograft as a cause of severe proteinuria. A 38-year-old male presented with end-stage renal disease. He underwent live related renal allograft transplant. His immediate post-transplant period was unremarkable. He de...
متن کامل